Effect of Donor and Recipient Diabetes Status on Descemet Membrane Endothelial Keratoplasty Adherence and Survival

Cornea

Volumn 36, Issue 10, 2017, Pages 1184-1188

  Price, Marianne O ^a   Lisek, Marek ^a   Feng, Matthew T ^b   Price, Francis W ^b  

^a Lautert)   (United States)

^b PRICE VISION GROUP   (United States)

Author keywords

air reinjection; Descemet membrane endothelial keratoplasty; diabetes; DMEK; DSAEK; DSEK; endothelial cell density; endothelial cell loss; insulin; keratoplasty survival; penetrating keratoplasty; rebubbling

Indexed keywords

INSULIN;

ADULT; ARTICLE; CASE STUDY; CELL DENSITY; CLINICAL OUTCOME; CORNEAL ENDOTHELIAL CELL LOSS; DESCEMET MEMBRANE ENDOTHELIAL KERATOPLASTY; DIABETES MELLITUS; DONOR; ENDOTHELIUM CELL; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TISSUE PREPARATION; AGED; CONGENITAL CORNEA DYSTROPHY; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY;

AGED; CORNEAL ENDOTHELIAL CELL LOSS; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; DIABETES MELLITUS; FEMALE; FUCHS' ENDOTHELIAL DYSTROPHY; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANT RECIPIENTS;

EID: 85026345399     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000001305     Document Type: Article

References (24)

1. Margo JA, Munir WM, Brown CH, et al. Association between endothelial cell density and transplant suitability of corneal tissue with Type 1 and Type 2 diabetes. JAMA Ophthalmol. 2016 [epub ahead of print].
2. Lutty GA. Effects of diabetes on the eye. Invest Ophthalmol Vis Sci. 2013;54:ORSF81-ORSF87.
3. Dhasmana R, Singh IP, Nagpal RC. Corneal changes in diabetic patients after manual small incision cataract surgery. J Clin Diagn Res. 2014;8: VC03-VC06.
4. Storr-Paulsen A, Singh A, Jeppesen H, et al. Corneal endothelial morphology and central thickness in patients with type II diabetes mellitus. Acta Ophthalmol. 2014;92:158-160.
5. Urban B, Raczynska D, Bakunowicz-Kazarczyk A, et al. Evaluation of central corneal thickness in children and adolescents with type I diabetes mellitus. Klin Oczna. 2007;109:418-420.
6. Lass JH, Riddlesworth TD, Gal RL, et al. The effect of donor diabetes history on graft failure and endothelial cell density 10 years after penetrating keratoplasty. Ophthalmology. 2015;122:448-456.
7. Vislisel JM, Liaboe CA, Wagoner MD, et al. Graft survival of diabetic versus nondiabetic donor tissue after initial keratoplasty. Cornea. 2015; 34:370-374.
8. Price MO, Thompson RW Jr, Price FW Jr. Risk factors for various causes of failure in initial corneal grafts. Arch Ophthalmol. 2003;121: 1087-1092.
9. Eye Bank Association of America. 2016 Eye Banking Statistical Report. Available at: http://restoresight.org. Accessed March 29, 2017.
10. Schwarz C, Aldrich BT, Burckart KA, et al. Descemet membrane adhesion strength is greater in diabetics with advanced disease compared to healthy donor corneas. Exp Eye Res. 2016;153:152-158.
11. Greiner MA, Rixen JJ, Wagoner MD, et al. Diabetes mellitus increases risk of unsuccessful graft preparation in Descemet Membrane Endothelial Keratoplasty: a multicenter study. Cornea. 2014;33:1129-1133.
12. Vianna LMM, Stoeger CG, Galloway JD, et al. Risk factors for eye bank preparation failure of Descemet Membrane Endothelial Keratoplasty (DMEK) tissue. Am J Ophthalmol. 2015;159:829-834.
13. Williams RS, Mayko ZM, Friend DJ, et al. Descemet Membrane Endothelial Keratoplasty (DMEK) tissue preparation: a donor diabetes mellitus categorical risk stratification scale for assessing tissue suitability and reducing tissue loss. Cornea. 2016;35:927-931.
14. Price MO, Giebel AW, Fairchild KM, et al. Descemet's membrane endothelial keratoplasty: prospective multi-center study of visual and refractive outcomes and endothelial survival. Ophthalmology. 2009;116: 2361-2368.
15. Tenkman LR, Price FW, Price MO. Descemet membrane endothelial keratoplasty donor preparation: navigating challenges and improving efficiency. Cornea. 2014;33:319-325.
16. Chaurasia S, Price FW Jr, Gunderson L, et al. Descemet's membrane endothelial keratoplasty: clinical results of single versus triple procedures (combined with cataract surgery). Ophthalmology. 2014;121:454-458.
17. Burkhart ZN, Feng MD, Price MO, et al. Handheld slit beam techniques to facilitate DMEK and DALK. Cornea. 2013;32:722-724.
18. Gonzalez A, Price FW Jr, Price MO, et al. Prevention and management of pupil block after Descemet membrane endothelial keratoplasty. Cornea. 2016;35:1391-1395.
19. Liaboe CA, Aldrich BT, Carter PC, et al. Assessing the impact of diabetes mellitus on donor corneal endothelial cell density. Cornea. 2017;36:561-566.
20. Chen Y, Tsao SW, Heo M, et al. Age-stratified analysis of diabetes and pseudophakia effects on corneal endothelial cell density: a retrospective eye bank study. Cornea. 2017;36:367-371.
21. Schlotzer-Schrehardt U, Bachmann BO, Laaser K, et al. Characterization of the cleavage plane in Descemet's membrane endothelial keratoplasty. Ophthalmology. 2011;118:1950-1957.
22. The Writing Committee for the Cornea Donor Study Research Group, Sugar A, Gal RL, et al. Factors predictive of corneal graft survival in the Cornea Donor Study. JAMA Ophthalmol. 2015;133:246-254.
23. Center for Disease Control and Prevention. 2014 National Diabetes Statistics Report. Available at: https://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed July 17, 2017.
24. Soper MC, Marcovina SM, Hoover CK, et al. The validity of postmortem glycated hemoglobin to determine status of diabetes mellitus in corneal donors. Cornea. 2017;36:942-947.